Загрузка...
Biological therapies for atrial fibrillation: ready for prime time?
Atrial fibrillation is a prominent cause of morbidity and mortality in developed countries. Treatment strategies center on controlling atrial rhythm or ventricular rate. The need for anticoagulation is an independent decision from the rate vs. rhythm control debate. This review discusses novel biolo...
Сохранить в:
| Опубликовано в: : | J Cardiovasc Pharmacol |
|---|---|
| Главный автор: | |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4879872/ https://ncbi.nlm.nih.gov/pubmed/26222989 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FJC.0000000000000293 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|